Filing Flows › Regen BioPharma (RGBP) › How it makes money
How Regen BioPharma (RGBP) makes money
Regen BioPharma (RGBP) made $59K of revenue in the third quarter fiscal 2026 (Q3 FY26), 0% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $59K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $59K | 0% |
| Q2 FY26 | $59K | 0% |
| Q1 FY26 | $59K | 0% |
| Q3 FY25 | $59K | 0% |
| Q2 FY25 | $59K | 0% |
| Q4 FY24 | $59K | — |
From Regen BioPharma's 10-Q filed Aug 17, 2026 (on EDGAR).
Questions
How does Regen BioPharma make money?
Regen BioPharma (RGBP) made $59K of revenue in the third quarter fiscal 2026 (Q3 FY26), 0% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.